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Abstract Nutritional systems biology is an evolving
research field aimed at understanding nutritional processes
at a systems level. It is known that the development of cancer
can be influenced by the nutritional status, and the link
between vitamin D status and different cancer types is
widely investigated. In this study, we performed an inte-
grative network-based analysis using a publicly available
data set studying the role of 1,25-dihydroxyvitamin D3
(1,25(OH)2D3) in prostate cancer cells on mRNA and
microRNA level. Pathway analysis revealed 15 significantly
altered pathways: eight more general mostly cell cycle-re-
lated pathways and seven cancer-specific pathways. The
changes in the G1-to-S cell cycle pathway showed that
1,25(OH)2D3 down-regulates the genes influencing the G1-
to-S phase transition. Moreover, after 1,25(OH)2D3 treat-
ment the gene expression in several cancer-related processes
was down-regulated. The more general pathways were
merged into one network and then extended with known
protein–protein and transcription factor–gene interactions.
Network algorithms were used to (1) identify active network
modules and (2) integrate microRNA regulation in the net-
work. Adding microRNA regulation to the network enabled
the identification of gene targets of significantly expressed
microRNAs after 1,25(OH)2D3 treatment. Six of the nine
differentially expressed microRNAs target genes in the
extended network, including CLSPN, an important check-
point regulator in the cell cycle that was down-regulated, and
FZD5, a receptor for Wnt proteins that was up-regulated.
The extendable network-based tools PathVisio and Cytos-
cape enable straightforward, in-depth and integrative anal-
ysis of mRNA and microRNA expression data in
1,25(OH)2D3-treated cancer cells.
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Introduction
Nutritional systems biology is an evolving research field
aimed at understanding nutritional processes at a systems
level. Integrating the effects of nutritional compounds at
the gene expression level with information about the reg-
ulatory level can shed a new light on their action
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mechanism. Promising regulatory molecules in this respect
are small non-coding RNAs, like microRNAs, which reg-
ulate gene expression post-transcriptionally. Nowadays
high-throughput technologies enable the measurements of
mRNA and microRNA expression on a large scale. Path-
way- and network-based approaches are meaningful for the
integrated analysis of these two types of omics data. The
present study demonstrates how pathway analysis can be
combined with network analysis to perform an integrated
analysis of transcriptomics and microRNA-omics data. The
integrative analysis uses two widely adopted open source
tools for pathway and network analysis: PathVisio (Kut-
mon et al. 2015) and Cytoscape (Shannon et al. 2003).
System nutrition
Nutritional status is known to influence cancer develop-
ment (Andreoli et al. 2011; McMillan 2009). The link
between the vitamin D status and different types of cancer
is widely investigated (Hatse et al. 2012; Shui and Gio-
vannucci 2014). The present study explores the role of the
biologically active form of vitamin D3, 1,25-dihydroxyvi-
tamin D3 (1,25(OH)2D3), in prostate cancer. Several stud-
ies suggest that adequate vitamin D levels have a protective
effect with respect to the development of prostate cancer,
and it is believed that vitamin D has chemopreventive
properties. Recently, a study by Wang et al. (2011)
investigated the 1,25(OH)2D3-mediated intracellular path-
ways by measuring global gene expression in LNCaP
prostate cancer cells. In addition, they examined the
expression of microRNAs in these cells upon treatment
with 1,25(OH)2D3. Wang et al. (2011) clearly showed that
1,25(OH)2D3 can modulate gene and microRNA profiles in
LCNaP cells and affects processes involved in cell cycle
arrest, calcium ion homoeostasis and phosphoinositide-
mediated signalling. In the present study, we will combine
pathway- and network-based methods to decipher the
regulatory action of 1,25(OH)2D3 in prostate cancer cells
on mRNA and microRNA level.
Materials and methods
Transcriptomics and microRNA data sets
In the Gene Expression Omnibus (GEO, http://ncbi.nlm.
nih.gov/geo/, Barrett and Edgar 2006), we found two
studies in which global gene expression was measured in
1,25(OH)2D3-treated prostate cells, accession numbers:
GSE17461 and GSE15947. After a thorough analysis, we
selected the study by Wang et al. (2011) because they used
prostate cancer cells (LNCaP cells), whereas Kovalenko
et al. (2010) used non-tumourigenic prostate cells (RWPE1
cells). Moreover, only in the LNCaP cells the microRNA
expression was measured in addition to the mRNA
expression, thereby adding the needed regulatory level.
The mRNA and microRNA expression measured in the
study by Wang et al. (2011) was used in this analysis.
These data are published and publicly available in GEO
(accession numbers GSE17461 and GSE23814). LNCaP
human prostate cancer cells were plated at a density of
1 9 106 cells per 150 cm2 for 48 h prior to treatment with
100 nM 1,25(OH)2D3; see Wang et al. (2011) for further
details. Total RNA was isolated from the LNCaP cells
using standard protocols. Gene expression was measured
with Nimblegen-HG18-4plex whole-genome microarrays
in 1,25(OH)2D3-treated (n = 3) and non-treated (control,
n = 3) LNCaP cells. Agilent human microRNA v3
microarrays were used to measure microRNA expression in
1,25(OH)2D3-treated (n = 4) and non-treated (control,
n = 4) cells.
Further pre-processing and quality control were per-
formed by Wang et al. (2011) as previously described.
GeneSpring GX10 software was used to check the data
quality of the raw data and to normalize the data with
RNA. They filtered the obtained gene list to remove probes
that showed a low signal value (i.e. bottom 20th percentile)
over all samples. Thereafter they used one-way ANOVA
(p\ 0.05) to find significantly changed genes when com-
paring 1,25(OH)2D3-treated cells versus non-treated cells.
Within each test, correction for multiple testing was per-
formed. A fold change (FC) cut-off at 1.5-fold was used to
obtain a final list of differentially expressed genes.
Also the raw microRNA data were pre-processed in
GeneSpring GX10. In the microRNA list, probes with a
low signal (i.e. bottom 20th percentile) were excluded in all
groups. In addition, only probes which were present in at
least three biological replicates and in all groups were
taken into account. MicroRNAs with fold changes greater
than 2.0 were considered significant when p\ 0.05 using
one-way ANOVA with correction for multiple testing. In
the next analysis steps, the statistically analysed data of
both gene expression and microRNA expression generated
by Wang et al. (2011) were used.
Pathway analysis
Pathway analysis was performed using PathVisio (version
3.1.3), a commonly used tool to create, visualize and
analyse biological pathways (Kutmon et al. 2015). The
human pathway collection from WikiPathways [Kelder
et al. (2012), curated collection with 276 pathways down-
load on 29 January 2015] was used to perform an over-
representation analysis with the transcriptomics data set.
The pathways were then ranked based on a standardized
difference score (Z score). A pathway was considered
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altered when (1) Z score[1.96, (2) permutation p value
\0.05 and (3) minimum number of differentially expressed
genes (|FC|[ 1.5, p value\0.05) in the pathway is five.
Network analysis
Network of interconnected pathways
Cytoscape is a widely adopted network visualization and
analysis tool (Shannon et al. 2003). In this study, the
WikiPathways app for Cytoscape (Kutmon et al. 2014) was
used to load the altered pathways as networks and then
merge them into one large network using Cytoscape’s
merge function. An identifier mapping step was performed
using the BridgeDb app for Cytoscape to unify the iden-
tifiers in the selected pathways (Gao et al. 2014). Thus,
unified pathway elements, i.e. gene products, metabolites
or pathway nodes, that are present in two or more pathways
are linking the pathways to each other in the network.
Network extension
The network of interconnected pathways was extended
with known protein–protein and transcription factor–target
interactions (first neighbours) between the genes in the
pathways and all other differentially expressed genes.
Protein–protein interactions were obtained from the
STRING database (Franceschini et al. 2013, medium
confidence level, score[0.4), and the transcription factor–
target interactions were extracted from the ENCODE pro-
ject (Gerstein et al. 2012). The created network will be
addressed as the vitamin D-extended network.
Active network modules
Active network modules are small, connected subnetworks
that contain genes that show significant changes in
expression. The jActiveModules app in Cytoscape was
used to identify active modules in the vitamin D-extended
network (Ideker et al. 2002). We selected the highest
scoring active module and used the ClueGO app (version
2.1.5) for Cytoscape to perform a functional analysis
(Bindea et al. 2009). It performs an enrichment analysis of
the genes in the active module to find relevant Gene
Ontology (GO) classes. A ClueGO network was created
with kappa statistics, which reflects the relationships
between the GO classes, based on the similarity of their
associated genes.
Vitamin D-microRNA network
Using the CyTargetLinker app in Cytoscape (Kutmon et al.
2013), microRNA–target gene interactions frommiRTarBase
(Hsu et al. 2014, version 4.5) and TargetScan (Grimson et al.
2007, version 6.2) were added to the network. A subnetwork
of differentially expressed microRNAs in the 1,25(OH)2D3-
treated cells with their target genes was created. In this step,
the microRNA and mRNA expression levels were integrated
and visualized together in the subnetwork.
Vitamin D receptor target analysis
In a literature search in NCBI PubMed (www.ncbi.nlm.nih.
gov/pubmed), we manually extracted 178 human vitamin D
receptor (VDR) target genes from 25 different articles and
books. First, the studies of interest were collected based on
the following search terms: ‘‘VDR target gene’’, ‘‘vitamin D
receptor’’, ‘‘VDR’’ or ‘‘gene regulation vitamin D’’. These
search terms were also used to find relevant information in
(online) books at the Maastricht University Library. Second,
relevant studies were selected when the title and/or abstract
included information on VDR target genes. Third, the
methods used to determine the VDR target genes were
manually verified and included ChIP sequencing, RNA
sequencing and microarrays. Finally, all human VDR target
genes from the selected studies were included in the anal-
ysis. Some of the target genes were reported in up to seven
different articles, others only in one; see Supplementary
Material 1. In the interpretation of the network of inter-
connected pathways and the extended network, the presence
and location of the VDR target genes were investigated.
Results and discussion
In this section, the six steps of our analysis will be pre-
sented. The basic principles are shown in Fig. 1. The goal
is the integrative analysis of transcriptomics and micro-
RNA expression data using pathway- and network-based
approaches. Starting with pathway analysis of the tran-
scriptomics data set, it was possible to identify a set of
altered pathways in 1,25(OH)2D3-treated prostate cancer
cells. Those pathways were then combined and merged into
one larger network to study the interplay and connections
between the pathways. To include more of the differen-
tially expressed genes that are not present in any of the
pathways, the network was extended with protein–protein
and transcription factor–target interactions to include the
first neighbours of the gene products in the pathways. To
explore the extended network in more detail, relevant up-
and/or down-regulated network modules were identified to
highlight the active parts in the network. As a last step, the
network was extended with microRNA–target interactions
from validated and prediction databases. In this step, the
microRNA expression data can be included and combined
with the mRNA data and subnetworks of differentially
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expressed microRNAs and their neighbours can be studied
in detail.
Transcriptomics and microRNA data sets
Statistical analysis performed in Wang’s study revealed
that 833 genes were differentially expressed in LNCaP
cells treated with 1,25(OH)2D3. Many of these genes are
known to be vitamin D-responsive genes (Krishnan et al.
2004; Peehl et al. 2004; Wang et al. 2005). A complete list
of the differentially expressed genes is available in the
additional file six of Wang et al. (2011). Four hundred and
twenty genes were found to be up-regulated and 413 genes
down-regulated in the 1,25(OH)2D3-treated cells.
Additionally to the transcriptomics data, Wang et al.
(2011) examined the effect of 1,25(OH)2D3 on microRNA
expression. They identified nine significantly up-regulated
microRNAs in 1,25(OH)2D3-treated cells with a fold
change greater than two. No down-regulated microRNAs
were found.
Pathway analysis
Pathway analysis in PathVisio using the WikiPathways
human collection of curated pathways revealed 15
altered pathways in the 1,25(OH)2D3-treated prostate
cancer cells (see Table 1). The results confirm the con-
clusions of the study by Wang that 1,25(OH)2D3 affects
cell cycle activity. Additionally, the related DNA repli-
cation and damage response pathways are changed.
Interestingly, there are seven cancer-related pathways
that are significantly altered in 1,25(OH)2D3-treated
cancer cells: RB in cancer, gastric cancer networks 1 and
2, integrated pancreatic cancer pathway, integrated
breast cancer pathway, integrated cancer pathway and
signalling pathways in glioblastoma. Out of 833 differ-
entially expressed genes, the significantly altered path-
ways contain 73 regulated genes, 14 up-regulated and 59
down-regulated.
The pathway diagrams of all significantly altered path-
ways are available in Supplementary Material 2.
Fig. 1 Integrative network-based analysis. This overview figure
highlights the different steps in the integrative network-based analysis
used in this study. The goal is to integrate different omics data sets
like mRNA and microRNA expression data (1). First, the mRNA
expression data were analysed using biological pathways and
significantly altered pathways were identified (2). The selected
pathways were then merged into one network (3). In the next step,
the network was extended with protein–protein and transcription
factor–gene interactions with other differentially expressed genes that
are not present in the pathways (4). The extended network was used to
first identify active modules (5a), and then, it was extended with
microRNA regulation, which allowed the integration of microRNA
expression data (5b)
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Network of interconnected pathways
The 15 altered pathways were grouped in a group of
explicitly cancer-related pathways and a group of more
general (mostly cell cycle related) pathways (see Table 1).
The eight more general pathways were merged into one
large network containing 503 nodes and 743 edges (see
Fig. 2a). The nodes consist of 319 gene products, 28
metabolites and 15 nodes linking to other pathways. The
remaining 141 nodes are used to represent groups and
complex interactions.
The network of interconnected more general pathways
contains 81 nodes that are present in more than one path-
way and are therefore linking the different pathways to
each other. TP53, CDKN1A and CDK2, three genes known
to play important roles in the cell cycle process, are linking
Table 1 Ranked biological pathways based on Z score
Pathway Positive Measured Z score p value Cancer/general
Retinoblastoma (RB) in cancer 35 87 12.63 0.001 Cancer
DNA replication 22 42 11.91 0.001 General
Cell cycle 34 100 11.04 0.001 General
Gastric cancer network 1 15 26 10.44 0.001 Cancer
Histone modifications 25 64 10.44 0.001 General
G1-to-S cell cycle control 23 67 9.12 0.001 General
DNA damage response 15 64 5.4 0.001 General
Gastric cancer network 2 9 30 5.13 0.001 Cancer
ATM signalling pathway 10 38 4.87 0.001 General
Fluoropyrimidine activity 8 32 4.16 0.001 General
Integrated pancreatic cancer pathway 27 195 4.08 0.001 Cancer
Integrated cancer pathway 8 35 3.85 0.005 Cancer
Integrated breast cancer pathway 21 157 3.41 0.002 Cancer
Arylhydrocarbon receptor (AhR) signalling pathway 5 27 2.47 0.015 General
Signalling pathways in glioblastoma 10 82 2.02 0.048 Cancer
Pathway statistics identified 15 significantly altered pathways in 1,25(OH)2D3-treated prostate cancer cells (Z score[1.96, p value\0.05 and
minimum number of positive genes is five). Besides eight more general cell cycle-related pathways, pathway analysis also revealed seven cancer-
specific pathways that are changed. Measured is number of gene products in the pathway that are measured in the data set, and positive is the
number of differentially expressed genes in the pathway
Fig. 2 Network of interconnected more general pathways. Pathway
analysis revealed eight significantly altered more general pathways in
1,25(OH)2D3-treated cancer cells. The pathways were merged into
one network using the WikiPathways and BridgeDb apps for
Cytoscape. a The fill colours of the nodes in the network indicate
their affiliation with one of the more general pathways. Yellow nodes
in the network highlight pathway elements linking two or more
pathways to each other. b Fourteen genes in the network are up-
regulated (red) and 59 genes are down-regulated (blue) in
1,25(OH)2D3-treated cancer cells
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five out of eight pathways and therefore are very central
nodes in the network. Seven out of eight pathways are
connected in one large network. Five of the eight pathways
are tightly linked through many shared pathway elements,
DNA replication, cell cycle, G1-to-S cell cycle control,
DNA damage response and ATM signalling pathways. The
AhR signalling pathway connects through four gene
products to four of the other pathways, JUN, BAX,
CDKN1A and CDKN1B. The fluoropyrimidine activity
pathway is linked by two nodes to four other pathways, the
TP53 gene product and the apoptosis pathway node. The
histone modifications pathway is not connected to any of
the other pathways.
The network of interconnected more general pathways
contains 73 differentially expressed genes (see Fig. 2b).
Fourteen genes in the network are up-regulated in
1,25(OH)2D3-treated cells. Only one of the up-regulated
genes is present in more than one pathway, ABL1 a gene
involved in cell differentiation, cell division, cell adhesion
and stress response. Twenty-eight out of 59 down-regu-
lated genes are linking two or more pathways. CDK1 and
CCNB1 are both significantly down-regulated and present
in four out of eight pathways. Both are key players in cell
cycle regulation.
Additionally, the seven cancer-related pathways were
merged into a network; see Supplementary Material 3. This
network contains 540 nodes and 951 edges. Out of 440
gene products, 18 are up-regulated and 66 are down-reg-
ulated indicating a down-regulation of cancer pathways in
1,25(OH)2D3-treated cancer cells. In the following steps,
we will only use the network of interconnected more
general pathways.
Network extension
Although 73 differentially expressed genes are present in
the network of interconnected more general pathways,
many of the differentially expressed genes in the data set
are missing. Therefore, the network was extended with
known first neighbours of the genes in the pathways to
evaluate whether that increases the coverage of the dif-
ferentially expressed genes found.
First, the network was extended with known protein–
protein interactions from the STRING database, and we
found 443 additional significantly changed genes that are
first neighbours of one of the genes in the pathways. In a
next step, we added transcription factor–target interactions
from ENCODE and found 67 new differentially expressed
genes that are directly linked to one of the genes in the
pathways.
The vitamin D-extended network consists of 1013 nodes
and 9200 edges. Five hundred and three nodes were from
the selected more general pathways (73 differentially
expressed), 443 nodes were added as first neighbours from
STRING and 67 nodes were extracted from the ENCODE
transcription factor-target network. So in total, the network
now contains 70 % of the differentially expressed genes
(583 out of 833, 345 down-regulated and 238 up-regulated
genes); see Supplementary Material 4. The first neighbours
also connect the histone modification pathway to the other
pathways in the network.
Active network modules
The vitamin D-extended network comprises all genes in the
selected pathways and a large part of the differentially
expressed genes. Using the jActiveModules app in Cytos-
cape, connected small subnetworks (modules) in the vita-
min D-extended network were identified in which gene
expression was regulated by 1,25(OH)2D3 treatment. The
analysis revealed ten different active modules, the highest
scoring module (score = 18.9) contained 193 down-regu-
lated genes. Forty-one nodes in the module were present in
the significantly altered pathways.
We then used the Cytoscape app ClueGO to find bio-
logical processes in which the genes in the module are
involved to identify important functions of the active
subnetwork. ClueGO created a network of interconnected
GO biological processes based on the similarity of their
associated genes (see Fig. 3). Supplementary Material 5
shows all the relevant GO processes and their associated
genes in the active module. The network of GO processes
contains biological processes involved in DNA processing,
cell cycle activity, organelle organization and phosphory-
lation. This is in accordance with the results of the pathway
analysis, which already pointed strongly towards cell
cycle-related processes.
Vitamin D-microRNA network
Using the CyTargetLinker app in Cytoscape, a regulatory
layer of microRNAs was added to the network. One
thousand four hundred and thirty-nine microRNA nodes
and 25,886 microRNA–target interactions were found
when combining the information from the prediction
database TargetScan (version 6.2—23,091 interaction) and
the validated database miRTarBase (version 4.5—2795
interactions). Six of the nine differentially expressed
microRNAs in the data set were found in this new vitamin
D-microRNA network, hsa-miR-29a, hsa-miR-371-5p,
hsa-miR-1915, hsa-miR-663, hsa-miR-134 and hsa-miR-
542-5p. All six are up-regulated in 1,25(OH)2D3-treated
cancer cells. Consequently, we selected the six up-regu-
lated microRNAs in the network and created a subnetwork
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with all their targets in the network (see Fig. 4). All
microRNAs target genes in the pathways (diamonds) and
extended first neighbours (ellipses).
Fifty out of 96 targets are present in the altered path-
ways (shown as diamonds in Fig. 4), but only seven
pathway genes are differentially expressed. Five out of
those seven are gene products that link two or more path-
ways to each other. The six up-regulated microRNAs target
genes in all eight more general pathways.
Except for hsa-miR-134, all other microRNAs target up-
and down-regulated genes. Interactions for hsa-miR-371-
5p, hsa-miR-1915 and hsa-miR-134 are only present in the
prediction database TargetScan. The microRNA hsa-miR-
542-5p has only interactions from the validated database
miRTarBase. The microRNAs hsa-miR-29a and hsa-miR-
663 have interactions from TargetScan and miRTarBase;
seven of them are even present in both databases, like hsa-
miR-663 ? JUND or hsa-miR-29a ? CPEB3.
Highlighting biological results
The presented integrative network-based analysis provides
a useful framework to study the effects of 1,25(OH)2D3 on
a process level as well as to define new hypotheses about
the mechanisms of 1,25(OH)2D3 in prostate cancer. In this
section, we would like to highlight several biological
results to showcase the relevance of the approach
described.
G1-to-S phase transition
The pathway analysis revealed that the G1-to-S cell cycle
pathway was among the altered pathways after
1,25(OH)2D3 treatment in LNCaP cells. This pathway had
a Z score of 9.12 (p value = 0.001) and contained 23
differentially expressed genes, 21 down-regulated genes
and 2 up-regulated genes. The pathway diagram visualizing
Fig. 3 ClueGO network for highest scoring active module. The
highest scoring active module in the network with 193 down-
regulated genes was identified using the jActiveModules app. Then,
the ClueGO app was used to find relevant GO processes, and a
network of connected GO terms was created. Each node represents a
GO biological process, and the colours represent the GO group. In
total, 34 GO groups and 8 GO processes not assigned to a group
(shown in grey) are present in the network. Per group one
representing GO biological process is named in the figure
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the differentially expressed genes is present in the Sup-
plementary Material 2. Yang and Burnstein (2003) showed
that 1,25(OH)2D3 could block the transition of the LNCaP
cells from the G1-to-S phase. They showed that after
1,25(OH)2D3 treatment the p27 protein levels increased
and that the nuclear localization of Cdk2 decreased,
resulting in a reduced Cdk2 activity. The gene expression
in the present study confirms the inhibition of the G1-to-S
transition. Among the down-regulated genes in our path-
way is cyclin CCNE2. CCNE2 forms a complex with and
regulates Cdk2. The decreased expression of CCNE2 after
1,25(OH)2D3 treatment might lead to a reduced Cdk2
activity, and in this way, it might prevent G1-to-S
transition.
Cancer-related pathways
Pathway databases like WikiPathways also store disease-
specific pathways. In our analysis, the pathway statistics
result in PathVisio also showed several cancer-related
pathways, which clearly indicates that the 1,25(OH)2D3
treatment affects cancer-related processes. The pathway
diagrams of the integrated cancer and RB in cancer path-
ways in the Supplementary Material 2 clearly show that
several cancer-related processes are down-regulated in
1,25(OH)2D3-treated prostate cancer cells. This confirms
several earlier studies and suggests that prostate cancer
patients may benefit from vitamin D treatment (Hatse et al.
2012; Shui and Giovannucci 2014).
Cytoskeleton organization
The GO analysis in the highest regulated module from the
vitamin D-extended network showed that the differentially
expressed genes in the module are present in cell cycle-
related GO processes. Interestingly, several processes are
associated with the cytoskeleton organization. In our
pathway analysis, the processes related to cytoskeleton
organization are not significantly changed by 1,25(OH)2D3.
However, Max et al. (2014) recently studied gene expres-
sion in rat muscle of newborns after maternal treatment
with vitamin D. They found that cell cycle and cytoskeletal
processes are altered after such a treatment. These pro-
cesses are similar to what we found in prostate cancer cells
Fig. 4 Vitamin D-microRNA network. MicroRNA–target interac-
tions from TargetScan and miRTarBase were added to the vitamin
D-extended network. Six out of nine differentially expressed
microRNAs in 1,25(OH)2D3-treated cancer cells were present in the
vitamin D-microRNA network. Those six up-regulated microRNAs
are highlighted as green rounded rectangles. Together they target 96
gene products present in pathways (diamonds) and added with
protein–protein and transcription factor–gene interactions (ellipses).
Up-regulated genes are coloured in red, and down-regulated genes are
coloured in blue. The edge colour indicates the source, either
TargetScan (blue) or miRTarBase (red). Seven target interactions are
present in both databases
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using GO analysis. Moreover, our approach demonstrates
that extending the network of interconnected pathways
with differentially expressed genes that are not in the
altered pathways can identify processes that are not sig-
nificant in pathway analysis.
VDR target analysis
Transcriptional regulation is a central process in humans,
and VDR is a member of the nuclear receptor family of
transcription factors. VDR is activated by 1,25(OH)2D3
and can form a heterodimer with RXR to regulate tran-
scription of many different target genes. In an extensive
literature search, we identified 178 genes that are known to
be regulated by VDR.
In 1,25(OH)2D3-treated prostate cancer cells, we found
21 VDR target genes that are differentially up-regulated
and two that are differentially down-regulated; see Sup-
plementary Material 1. CYP24A1 is the most up-regulated
gene in the experiment (FC = 56), and this mitochondrial
protein is responsible for the degradation of 1,25(OH)2D3.
An increase in expression after 1,25(OH)2D3 treatment is
therefore expected.
VDR targets in the network of interconnected path-
ways In the network of interconnected general pathways
that has been built from the significantly altered pathways,
ten of the gene products are known VDR targets. Most of
the targets are present in the G1-to-S cell cycle control
pathway. No targets have been found in two out of eight
pathways: histone modifications and fluoropyrimidine
activity. Only two of the targets are up-regulated (CDKN2B
and IGFBP1), and two are down-regulated (CDKN2C and
CDKN2D). Two out of three genes that connect five dif-
ferent pathways are known targets of VDR (CDKN1A and
CDK2), clearly showing that they play an important role in
response to 1,25(OH)2D3 treatment.
There are only three VDR targets in the network of
interconnected cancer-related pathways, MYC, CDKN2B
and CDKN2C. Interestingly, all three genes are differen-
tially expressed in 1,25(OH)2D3-treated prostate cancer
cells. CDKN2B is up-regulated, andMYC and CDKN2C are
down-regulated.
VDR targets in the extended network After the extension
with interactions from STRING and ENCODE, 17 of the
differentially expressed VDR targets are present in the
network. Six of the differentially expressed VDR targets
are not present in the extended network, CLMN, DND1,
ORM1, ORM2, SULT1C2 and STEAP4. ORM1 and ORM2,
for example, encode for the alpha-1-acid glycoprotein, an
acute-phase plasma protein that has been reported as a
possible prognostic factor of survival in cancer patients
(Bruno et al. 2003).
The VDR analysis showed that several known VDR
targets are significantly changed in 1,25(OH)2D3-treated
LNCaP cells and that they are mostly up-regulated. How-
ever, also the expression of other genes is affected by the
1,25(OH)2D3 treatment. This could indicate that they are
regulated either indirectly or independently of VDR.
Including knowledge on VDR targets added an additional
regulatory level to our network analysis.
MicroRNA targets
In the vitamin D-microRNA network, microRNA–target
interactions from TargetScan and miRTarBase were added
to the vitamin D-extended network. Five genes are targeted
by more than one microRNA, CLSPN, FZD5, CACNG4,
SET and MLL2. CLSPN is down-regulated, FZD5 and
CACNG4 are up-regulated, and SET and MLL2 are not
differentially expressed in 1,25(OH)2D3-treated cancer
cells. CLSPN is an important checkpoint regulator in the
cell cycle and is known to be down-regulated by
1,25(OH)2D3 treatment (Verlinden et al. 2007). This is also
shown in the vitamin D-microRNA network. FZD5 (Friz-
zled5), a receptor for Wnt proteins, is known to be affected
by 1,25(OH)2D3 treatment (Doroudi et al. 2014). CACNG4
is a calcium channel, and even though there is no direct
relation to vitamin D known, Wiki-pi, a Web server of
annotated human protein–protein interactions to aid the
discovery of protein function, shows that the known
interaction partners of CACNG4 are enriched in the GO
term ‘‘response to vitamin D’’ (Orii and Ganapathiraju
2012).
Features of our network-based integrative analysis
In this study, we showed how pathway- and network-based
approaches can be used to analyse and integrate different
omics measurements. Pathway analysis is a powerful tool
to analyse experimental data and puts the data into a bio-
logical context. Pathways are not closed systems, but they
interact and influence each other. In our analysis, we
merged all the significantly altered pathways into one
network to be able to get a more complete view of the
changes in the system. Additionally, it is possible to see
pathway elements that link different pathways to each
other.
Biological pathway databases like WikiPathways,
Reactome and KEGG are constantly growing, but there is
still a lot of information missing. Therefore, it is important
to combine pathway knowledge with information about
binary interactions like protein–protein or transcription
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factor–gene interactions. There are many online databases
storing such interactions, and by integrating them in the
network, more of the changes in the data set can be
included in the analysis. Instead of 73 differentially
expressed genes in the pathways, we were able to include
583 differentially expressed genes after extending the
network with protein–protein interactions from STRING
and transcription factor–gene interactions from ENCODE.
There are many different network algorithms that can be
used to investigate the vitamin D-extended network. In our
analysis, we selected two different approaches to demon-
strate the power of network analysis. A commonly used
method to find relevant parts in the network is the identi-
fication of active modules. Active modules are groups of
connected genes that are activated or repressed. Finding
active modules is a hard problem and jActiveModules
involves random sampling, so the calculation results might
slightly differ between two runs. In the vitamin D-extended
network, active modules were identified based on the gene
expression in 1,25(OH)2D3-treated prostate cancer cells
compared to non-treated cancer cells. The highest scoring
module of down-regulated genes seemed to be very robust,
with only a few genes added or removed. Functional
enrichment of the genes in the selected module in GO
biological processes was determined using the ClueGO
app. A network of interconnected GO processes showed
processes involved in DNA processing, cell cycle activity,
organelle organization and phosphorylation. In the net-
work, GO processes are linked and similar or deviating GO
processes become apparent.
In a second network analysis step, we included micro-
RNA–target interactions to make it possible to study the
microRNA and mRNA expression data together. The
microRNA–target interactions were added with the
CyTargetLinker app. We selected one validated (miRTar-
Base) and one prediction (TargetScan) database for this
step. Six out of nine differentially expressed microRNAs
were found in the network. It is now possible to extract the
subnetwork of the six microRNAs and all their targets. This
enables the user to study this relevant part of the network in
more detail.
Biological pathways consist of different types of gene
products and metabolites. The different types of gene
product types (DNA, RNA and protein) are often combined
in one entity, but the different types can also be mapped to
each other. That enables the integration and visualization
of omics data sets from different omics technologies (van
Iersel et al. 2014). However, biological pathways often do
not contain all the different regulatory elements like
microRNAs and transcription factors to keep the pathways
concise and understandable. By using network analysis, we
are now able to combine and integrate the different inter-
action and regulation levels and analyse and visualize
different omics data set, like mRNA and microRNA,
together.
All the approaches in this analysis are highly generic
and can be used for different data sets in human or other
species. The extension systems of software tools like
PathVisio and Cytoscape through plugins or apps allow
users to apply a variety of different methods within the
same framework which facilitates the analysis process and
saves a lot of time.
Challenges and future directions
In the present study, the effect of 1,25(OH)2D3 in prostate
cancer cells was investigated in vitro. Although it shows
how gene and microRNA expression in human prostate
cancer cells can be influenced by vitamin D, it would be of
interest to determine the whole-body effect of vitamin D.
Prostate cancer patients could benefit from vitamin D
treatment, and therefore, clinical studies investigating the
effect of vitamin D supplement on the global gene and
microRNA expression level in various tissues could shed a
new light on the vitamin D health effect. The approach in
the present study can be applied in a similar way to in vivo
vitamin D studies.
Finally, in addition to gene and microRNA expression
data, other types of data could be included into a network-
based analysis. By combining other characteristics like age,
gender, genetic variation, vitamin D blood levels before
and after supplementation or tumour size, patients could be
divided into subgroups which could respond differently to
the vitamin D treatment. Knowledge on the biological
processes or parts of the processes that are affected in
patients could tell whether vitamin D supplementation had
the desired effect or not.
Conclusion
In this analysis, we demonstrated how to integrate mRNA
and microRNA expression in 1,25(OH)2D3-treated prostate
cancer cells in a network-based analysis. By combining
biological pathways, protein–protein interactions, tran-
scription factor–gene interactions and microRNA regula-
tion data, it is possible to study the effect of 1,25(OH)2D3
treatment on a more systematic level.
Our approach showed that 1,25(OH)2D3 in LNCaP cells
affects gene expression in cell cycle-related processes
including the G1-to-S phase transition. Interestingly, also
several cancer-related processes are mostly down-regulated
in the 1,25(OH)2D3-treated cells.
Moreover, the expression of several VDR target genes,
which were among the 178 identified VDR target genes,
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were up-regulated after 1,25(OH)2D3 treatment, for
example CYP24A1, the most up-regulated gene in the
experiment (FC = 56.22), that is mitochondrial protein
responsible for the degradation of 1,25(OH)2D3.
Finally, the gene targets of the significantly expressed
microRNAs after 1,25(OH)2D3 treatment could be identi-
fied by adding microRNA regulation. Six of the nine dif-
ferentially expressed microRNAs target genes in the
extended network, including CLSPN, an important check-
point regulator in the cell cycle that is down-regulated, and
FZD5, a receptor for Wnt proteins that is up-regulated.
Taken together, this work also shows that the network-
based tools, PathVisio and Cytoscape, enable a straight-
forward, in-depth and biologically meaningful integrative
analysis of mRNA and microRNA expression.
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